🔎 Trials Near Me

Почетна › Akutna limfoblastna leukemija › Masachuset › Boston

Kliničke studije za Akutna limfoblastna leukemija u gradu Boston, MA

15 studija za Akutna limfoblastna leukemija traži učesnike na lokacijama u gradu Boston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Тражи се учесник
  • Dana-Farber/Boston Children s Hospital, Boston
Узраст од 1 до 25 · Оба пола · Ажурирано 13. 11. 2026. · NCT05621291

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Тражи се учесникФаза 2Здраве особе су добродошле
  • DFCI/BWH Brigham and Women's Hospital, Boston
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06059391

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Тражи се учесникФаза 1Здраве особе су добродошле
  • Brigham and Women's Hospital, Boston
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT07020533

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Тражи се учесникФаза 1/2
  • Dana-Farber Cancer Institute, Boston
Узраст од 16 до 75 · Оба пола · Ажурирано 10. 9. 2026. · NCT03104491

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • Dana-Farber Cancer Institute, Boston
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

ALL Backbone in AYAs

Тражи се учесникФаза 2
  • Dana Farber Cancer Institute, Boston
Узраст од 18 до 51 · Оба пола · Ажурирано 17. 8. 2026. · NCT07227584

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Тражи се учесникОпсервациона студија
  • Children's Hospital Corporation d/b/a Boston Children's Hospital, Boston
1 Day – 17 Years · Оба пола · Ажурирано 14. 8. 2026. · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Тражи се учесникОпсервациона студија
  • Tufts Medical Center, Boston
  • Beth Israel Deaconess, Boston
  • Dana Farber Cancer Institute, Boston
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Тражи се учесникОпсервациона студија
  • Dana-Farber Cancer Institute, Boston
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Тражи се учесникФаза 1
  • Dana Farber Cancer Institute, Boston
Узраст 13 и старији · Оба пола · Ажурирано 5. 5. 2026. · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Тражи се учесникФаза 1/2
  • Massachusetts General Hospital, Boston
Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Тражи се учесникФаза 2
  • Dana-Farber Cancer Institute, Boston
Узраст од 18 до 66 · Оба пола · Ажурирано 17. 3. 2026. · NCT06859424

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Тражи се учесникФаза 1
  • Dana-Farber Cancer Institute, Boston
Узраст од 1 до 40 · Оба пола · Ажурирано 12. 3. 2026. · NCT05292664

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Тражи се учесникФаза 1
  • Dana-Farber Cancer Institute, Boston
Узраст 18 и старији · Оба пола · Ажурирано 15. 4. 2025. · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Тражи се учесникФаза 1
  • Dana-Farber Cancer Institute, Boston
Узраст од 1 до 21 · Оба пола · Ажурирано 6. 12. 2024. · NCT05476770

Studije za Akutna limfoblastna leukemija u drugim gradovima

Ostale studije u gradu Boston

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.